Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Phase III, Randomized Trial of RIC and Transplantation of (dUCB) Versus HLA-Haplo Related Bone Marrow for Patients With Hematologic Malignancies.(BMT CTN #1101)

NCT01597778 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT01597778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01597778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Phase III, Randomized Trial of RIC and Transplantation of (dUCB) Versus HLA-Haplo Related Bone Marrow for Patients With Hematologic Malignancies.(BMT CTN #1101)
Lead sponsor
Medical College of Wisconsin
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2012
Completion date
September 11, 2020
Enrollment
368 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia, acute myelogenous leukemia, burkitt's lymphoma, follicular lymphoma, hodgkin lymphoma, mantle cell lymphoma, non-hodgkin lymphoma